These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 17130199)

  • 1. Botulinum toxin treatment for oropharyngeal dysphagia associated with diabetic neuropathy.
    Restivo DA; Marchese-Ragona R; Lauria G; Squatrito S; Gullo D; Vigneri R
    Diabetes Care; 2006 Dec; 29(12):2650-3. PubMed ID: 17130199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-lasting effect of a single botulinum toxin injection in the treatment of oropharyngeal dysphagia secondary to upper esophageal sphincter dysfunction: a pilot study.
    Terre R; Valles M; Panades A; Mearin F
    Scand J Gastroenterol; 2008; 43(11):1296-303. PubMed ID: 18649151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum toxin improves dysphagia associated with multiple sclerosis.
    Restivo DA; Marchese-Ragona R; Patti F; Solaro C; Maimone D; Zappalá G; Pavone A
    Eur J Neurol; 2011 Mar; 18(3):486-90. PubMed ID: 20731706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A retrospective study of 91 injections of botulinus toxin into the upper sphincter of the oesophagus].
    Verhulst J; Amé P; Guatterie M; Barat M; Traissac L
    Rev Laryngol Otol Rhinol (Bord); 2003; 124(5):315-20. PubMed ID: 15144028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful botulinum toxin treatment of dysphagia in a spinal muscular atrophy type 2 patient.
    Suzukia Y; Sano N; Shinonaga C; Fukuda M; Hyodo M; Morimoto T
    Brain Dev; 2007 Nov; 29(10):662-5. PubMed ID: 17532160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ALS dysphagia pathophysiology: differential botulinum toxin response.
    Restivo DA; Casabona A; Nicotra A; Zappia M; Elia M; Romano MC; Alfonsi E; Marchese-Ragona R
    Neurology; 2013 Feb; 80(7):616-20. PubMed ID: 23345638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum toxin injection in dysphagia syndromes with preserved esophageal peristalsis and incomplete lower esophageal sphincter relaxation.
    Porter RF; Gyawali CP
    Neurogastroenterol Motil; 2011 Feb; 23(2):139-44, e27-8. PubMed ID: 20939855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An electrophysiological approach to the diagnosis of neurogenic dysphagia: implications for botulinum toxin treatment.
    Alfonsi E; Merlo IM; Ponzio M; Montomoli C; Tassorelli C; Biancardi C; Lozza A; Martignoni E
    J Neurol Neurosurg Psychiatry; 2010 Jan; 81(1):54-60. PubMed ID: 19762326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum toxin treatment for oropharyngeal dysphagia in patients with stroke.
    Terré R; Panadés A; Mearin F
    Neurogastroenterol Motil; 2013 Nov; 25(11):896-e702. PubMed ID: 23991889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oropharyngeal dysphagia in polymyositis/dermatomyositis.
    Ertekin C; Seçil Y; Yüceyar N; Aydoğdu I
    Clin Neurol Neurosurg; 2004 Dec; 107(1):32-7. PubMed ID: 15567550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of botulinum toxin injection and upper esophageal sphincter myotomy in treating oropharyngeal dysphagia.
    Zaninotto G; Marchese Ragona R; Briani C; Costantini M; Rizzetto C; Portale G; Zanetti L; Masiero S; Costantino M; Nicoletti L; Polidoro A; Feltrin G; Angelini C; Ancona E; Guidolin D; Parenti AR
    J Gastrointest Surg; 2004 Dec; 8(8):997-1006. PubMed ID: 15585387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of botulinum toxin injections into the cricopharyngeus muscle of patients with cricopharyngeus dysfunction associated with pharyngo-laryngeal weakness.
    Woisard-Bassols V; Alshehri S; Simonetta-Moreau M
    Eur Arch Otorhinolaryngol; 2013 Mar; 270(3):805-15. PubMed ID: 22865104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cricopharyngeal Botox injection: indications and technique.
    Moerman MB
    Curr Opin Otolaryngol Head Neck Surg; 2006 Dec; 14(6):431-6. PubMed ID: 17099352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electromyography of human cricopharyngeal muscle of the upper esophageal sphincter.
    Ertekin C; Aydogdu I
    Muscle Nerve; 2002 Dec; 26(6):729-39. PubMed ID: 12451598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum toxin (BoNT) and back pain.
    Porta M; Maggioni G
    J Neurol; 2004 Feb; 251 Suppl 1():I15-8. PubMed ID: 14991338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Percutaneous chemical myotomy using botulium neurtoxin A under local anaesthesia in the treatment of cricopharyngeal dysphagia following laryngectomy.
    Natt RS; McCormick MS; Clayton JM; Ryall C
    Auris Nasus Larynx; 2010 Aug; 37(4):500-3. PubMed ID: 20036474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increasing severity of cardiac autonomic neuropathy is associated with increasing prevalence of nephropathy, retinopathy, and peripheral neuropathy in Turkish type 2 diabetics.
    Bilal N; Erdogan M; Ozbek M; Cetinkalp S; Karadeniz M; Ozgen AG; Saygili F; Yilmaz C; Tüzün M; Kabalak T
    J Diabetes Complications; 2008; 22(3):181-5. PubMed ID: 18413163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum toxin treatment of secretory disorders.
    Naumann M; Jost W
    Mov Disord; 2004 Mar; 19 Suppl 8():S137-41. PubMed ID: 15027066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum toxin injection for the treatment of upper esophageal sphincter dysfunction.
    Kelly EA; Koszewski IJ; Jaradeh SS; Merati AL; Blumin JH; Bock JM
    Ann Otol Rhinol Laryngol; 2013 Feb; 122(2):100-8. PubMed ID: 23534124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of cricopharyngeus muscle dysfunction.
    Kuhn MA; Belafsky PC
    Otolaryngol Clin North Am; 2013 Dec; 46(6):1087-99. PubMed ID: 24262961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.